Results 231 to 240 of about 26,727 (247)

Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1 , hM2 , hM3 , hM4 and hM5 using microphysiometry

British Journal of Pharmacology, 1999
Jeannette M Watson, F Brown, A J Hunter
exaly  

Muscarinic M1 agonists in the treatment of Alzheimer’s disease

Expert Opinion on Investigational Drugs, 2000
Amos D Korczyn
exaly  

Agonist-induced changes in the modulation of K+ permeability and beating rate by muscarinic agonists in cultured heart cells.

Journal of General Physiology, 1982
J B Galper, Dennis S Miura, Smith T W
exaly  

Synthesis and biochemical activity of novel amidine derivatives as m1 muscarinic receptor agonists

Bioorganic and Medicinal Chemistry, 1996
Peter I Nagy, William S Messer, S Periyasamy   +2 more
exaly  

In vivo characterisation of novel efficacious muscarinic receptor agonists

European Journal of Pharmacology, 1990
S B Freedman, E A Harley, Shil Patel
exaly  

Muscarinic agonists have no measurable effect on cGMP formation of rat pinealocytes

Brain Research Bulletin, 1993
L Vollrath, R Spessert
exaly  

A new use for muscarinic agonists?

Inpharma Weekly, 1993
openaire   +1 more source

Discovery of NovelN-Substituted Oxindoles as Selective M1and M4Muscarinic Acetylcholine Receptors Partial Agonists

ACS Medicinal Chemistry Letters, 2013
Takaaki Sumiyoshi, Takeshi Enomoto, Yoshiharu Uruno   +2 more
exaly  

Comparative Molecular Field Analysis on a Set of Muscarinic Agonists

QSAR and Combinatorial Science, 1991
Giovanni Greco, Ettore Novellino, A Vittoria   +2 more
exaly  

Muscarinic agonists for the treatment of Alzheimer’s disease: progress and perspectives

Expert Opinion on Investigational Drugs, 1997
Abraham Fisher
exaly